• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙厌氧菌对抗菌药物的耐药性

Resistance of anaerobic bacteria to antimicrobial agents in Spain.

作者信息

Baquero F, Reig M

机构信息

Department of Microbiology, Hospital Ramón y Cajal, National Institute of Health, Madrid, Spain.

出版信息

Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1016-20. doi: 10.1007/BF01967792.

DOI:10.1007/BF01967792
PMID:1295754
Abstract

As a consequence of antibiotic consumption, the entire microbial ecosystem attached to man is evolving towards resistance. In Spain, penicillin resistance (MIC > 0.5 mg/l) is found in about 10% of Peptostreptococcus, Clostridium perfringens and Eubacterium, and in 50% of Veillonella. Cefoxitin resistance ( > 2 mg/l) is present in 10 to 20% of Peptostreptococcus and Clostridium, and in 50% of Eubacterium; 21% of Bacteroides (fragilis group) strains are resistant to 16 mg/l. A very low rate of imipenem resistance (> or = 128 mg/l) is found among Bacteroides (1%), but for 5% of the isolates MICs of imipenem are 2 to 4 mg/l. Metronidazole resistance ( > 8 mg/l) is found in 5 to 10% of Peptostreptococcus, Clostridium and Veillonella, and in less than 1% of the Bacteroides fragilis group. Erythromycin resistance ( > 2 mg/l) is present in over two-thirds of the Peptostreptococcus, Veillonella and Fusobacterium isolates, and in 27% of the Clostridium perfringens strains. Clindamycin resistance ( > 4 mg/l) is found in 10 to 20% of the Peptostreptococcus, Clostridium and Eubacterium isolates, and in 20% of the Bacteroides of the fragilis group, this rate being higher (30%) among faecal isolates.

摘要

由于抗生素的使用,附着在人体上的整个微生物生态系统正朝着抗药性方向演变。在西班牙,约10%的消化链球菌、产气荚膜梭菌和真杆菌以及50%的韦荣球菌中发现有青霉素耐药性(最低抑菌浓度>0.5毫克/升)。10%至20%的消化链球菌和梭菌以及50%的真杆菌中存在头孢西丁耐药性(>2毫克/升);21%的拟杆菌(脆弱类杆菌群)菌株对16毫克/升耐药。在拟杆菌中发现亚胺培南耐药率极低(>或=128毫克/升)(1%),但5%的分离株中亚胺培南的最低抑菌浓度为2至4毫克/升。5%至10%的消化链球菌、梭菌和韦荣球菌以及不到1%的脆弱拟杆菌群中发现有甲硝唑耐药性(>8毫克/升)。超过三分之二的消化链球菌、韦荣球菌和梭杆菌分离株以及27%的产气荚膜梭菌菌株中存在红霉素耐药性(>2毫克/升)。10%至20%的消化链球菌、梭菌和真杆菌分离株以及20%的脆弱拟杆菌群拟杆菌中发现有克林霉素耐药性(>4毫克/升),粪便分离株中的这一比例更高(30%)。

相似文献

1
Resistance of anaerobic bacteria to antimicrobial agents in Spain.西班牙厌氧菌对抗菌药物的耐药性
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1016-20. doi: 10.1007/BF01967792.
2
Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.韩国厌氧菌对抗菌药物的新出现耐药性。
Clin Infect Dis. 1996 Dec;23 Suppl 1:S73-7. doi: 10.1093/clinids/23.supplement_1.s73.
3
[Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].[严格厌氧菌对甲硝唑、头孢西丁和克林霉素的敏感性]
Pathol Biol (Paris). 1985 Nov;33(9):899-903.
4
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.脆弱拟杆菌群物种及其他厌氧菌对美罗培南、亚胺培南、哌拉西林、头孢西丁、氨苄西林/舒巴坦、克林霉素和甲硝唑的敏感性比较。
J Antimicrob Chemother. 1993 Mar;31(3):363-72. doi: 10.1093/jac/31.3.363.
5
A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.通过传统的最低抑菌浓度(MIC)结果和统计方法对脆弱拟杆菌群及其他厌氧菌的药敏结果进行比较。
J Antimicrob Chemother. 1997 Mar;39(3):319-24. doi: 10.1093/jac/39.3.319.
6
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.BAY 12 - 8039与其他五种抗菌剂对厌氧菌的体外活性比较
Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):193-5. doi: 10.1007/BF01691117.
7
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Int J Antimicrob Agents. 1998 Nov;10(4):321-4. doi: 10.1016/s0924-8579(98)00052-1.
8
High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.台湾厌氧菌中头孢西丁和克林霉素耐药性的高发生率。
Antimicrob Agents Chemother. 2002 Sep;46(9):2908-13. doi: 10.1128/AAC.46.9.2908-2913.2002.
9
In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa.
J Antimicrob Chemother. 1998 Aug;42(2):245-8. doi: 10.1093/jac/42.2.245.
10
Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.1983年瑞典厌氧菌的抗菌药敏情况。
Scand J Infect Dis Suppl. 1984;43:44-9.

引用本文的文献

1
Comparative genomic analysis of food-animal-derived and human-derived isolates from markets in Shandong, China.中国山东市场上食品动物源和人源分离株的比较基因组分析。
Front Microbiol. 2025 Apr 1;16:1543511. doi: 10.3389/fmicb.2025.1543511. eCollection 2025.
2
Lung abscess as a complication of Lemierre Syndrome in adolescents: a single center case reports and review of the literature.青少年莱姆病综合征并肺脓肿:单中心病例报告及文献复习。
Ital J Pediatr. 2023 Aug 10;49(1):96. doi: 10.1186/s13052-023-01499-4.
3
Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

本文引用的文献

1
Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis.可转移的质粒连接氯霉素乙酰转移酶赋予均匀拟杆菌高水平抗性。
Antimicrob Agents Chemother. 1985 Jul;28(1):113-7. doi: 10.1128/AAC.28.1.113.
2
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.脆弱拟杆菌群各菌种对10种抗菌剂的敏感性。
Antimicrob Agents Chemother. 1990 Apr;34(4):671-3. doi: 10.1128/AAC.34.4.671.
3
Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
人类感染坏死梭杆菌(坏死杆菌病),重点关注勒米尔综合征。
Clin Microbiol Rev. 2007 Oct;20(4):622-59. doi: 10.1128/CMR.00011-07.
4
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.新型抗菌药物(曲伐沙星、莫西沙星、三氟沙星和奎奴普丁-达福普汀)对脆弱拟杆菌属的活性:与其他14种药物活性的比较。
Antimicrob Agents Chemother. 1999 Sep;43(9):2320-2. doi: 10.1128/AAC.43.9.2320.
5
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.亚胺培南/西司他丁:其抗菌活性、药代动力学及治疗严重感染疗效的最新进展
Drugs. 1996 Jan;51(1):99-136. doi: 10.2165/00003495-199651010-00008.
西班牙脆弱拟杆菌群菌株的抗菌药物敏感性演变
Rev Infect Dis. 1990 Jan-Feb;12 Suppl 2:S142-51. doi: 10.1093/clinids/12.supplement_2.s142.
4
Resistance of anaerobic bacteria to antimicrobial agents.厌氧菌对抗菌药物的耐药性。
Rev Infect Dis. 1991 Jan-Feb;13(1):183. doi: 10.1093/clinids/12.5.183.
5
Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.消化链球菌属对大环内酯类和林可酰胺类的耐药性:诱导型和组成型表型
Antimicrob Agents Chemother. 1992 Mar;36(3):662-4. doi: 10.1128/AAC.36.3.662.